LT-02 (phosphatidylcholine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LT-02 (phosphatidylcholine), covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) [Phase 3]